These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31164100)

  • 21. Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
    Brodie MJ; Fakhoury T; McDonough B; Colson AO; Stockis A; Elmoufti S; Whitesides J
    Epilepsy Res; 2018 Sep; 145():55-62. PubMed ID: 29908435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Rigby A; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; (12):CD007124. PubMed ID: 25470302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HLA-B*15:02 polymorphism and Tegretol
    Chouchi M; Kaabachi W; Tizaoui K; Daghfous R; Aidli SE; Hila L
    Rev Neurol (Paris); 2018 May; 174(5):278-291. PubMed ID: 29685430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2014 Feb; (2):CD007124. PubMed ID: 24488654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
    Minkova GD; Getova DP
    Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis.
    Zhang X; Liu J; Ye J
    Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients.
    Lu Q; Huang YT; Shu Y; Xu P; Xiang DX; Qu Q; Qu J
    Medicine (Baltimore); 2018 Jul; 97(30):e11662. PubMed ID: 30045320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variants in microsomal epoxide hydrolase influence carbamazepine dosing.
    Makmor-Bakry M; Sills GJ; Hitiris N; Butler E; Wilson EA; Brodie MJ
    Clin Neuropharmacol; 2009; 32(4):205-12. PubMed ID: 19620853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of the association of SCN1A gene polymorphisms with the retention rate of carbamazepine following monotherapy for new-onset focal seizures in the Chinese Han population.
    Zhou BT; Zhou QH; Yin JY; Li GL; Xu XJ; Qu J; Liu D; Zhou HH; Liu ZQ
    Clin Exp Pharmacol Physiol; 2012 Apr; 39(4):379-84. PubMed ID: 22292851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative methylation level of the EPHX1 promoter in peripheral blood DNA is associated with polycystic ovary syndrome.
    Sang Q; Li X; Wang H; Wang H; Zhang S; Feng R; Xu Y; Li Q; Zhao X; Xing Q; Jin L; He L; Wang L
    PLoS One; 2014; 9(2):e88013. PubMed ID: 24505354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy.
    Srivastava AK; Alex AB; Wilcox KS; White HS
    Epilepsia; 2013 Jul; 54(7):1186-94. PubMed ID: 23750799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbamazepine clearance and seizure stability during pregnancy.
    Johnson EL; Stowe ZN; Ritchie JC; Newport DJ; Newman ML; Knight B; Pennell PB
    Epilepsy Behav; 2014 Apr; 33():49-53. PubMed ID: 24632353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy.
    Bondareva IB; Jelliffe RW; Andreeva OV; Bondareva KI
    J Clin Pharm Ther; 2011 Oct; 36(5):625-36. PubMed ID: 21062333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamazepine-induced thrombocytopenia and carbamazepine-10,11-epoxide: a case report.
    Kimura M; Yoshino K; Maeoka Y; Suzuki N
    Psychiatry Clin Neurosci; 1995 Mar; 49(1):69-70. PubMed ID: 8608438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis.
    Santhosh AP; Kumar Goyal M; Modi M; Kharbanda PS; Ahuja CK; Tandyala N; Prabhat N; Singh R; Mehta S; Vinay Mahesh K
    Acta Neurol Scand; 2021 Mar; 143(3):242-247. PubMed ID: 33006755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of xenobiotic receptor polymorphisms with carbamazepine response in epilepsy patients.
    Kong FC; Ma CL; Lang LQ; Zhong MK
    Gene; 2021 Mar; 771():145359. PubMed ID: 33333223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
    Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
    Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.